Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg

Development and Clinical Application of A Rapid IgM‐IgG Combined Antibody Test for SARS‐CoV‐2 Infection Diagnosis

(2020) Zhengtu Li et al.   JOURNAL OF MEDICAL VIROLOGY

SARS‐CoV ‐2 and Multiple Sclerosis: Not All Immune Depleting DMTs are Equal or Bad

(2020) Sandra Amor et al.   ANNALS OF NEUROLOGY

The paramount importance of serological surveys of SARS-CoV-2 infection and immunity

(2020) Jaap Goudsmit   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Disability through COVID‐19 pandemic: Neurorehabilitation cannot wait

(2020) Letizia Leocani et al.   EUROPEAN JOURNAL OF NEUROLOGY

Serology characteristics of SARS-CoV-2 infection since exposure and post symptom onset

(2020) Bin Lou et al.   EUROPEAN RESPIRATORY JOURNAL

Seroprevalence of SARS-CoV-2–Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020

(2020) Neeraj Sood et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Interpreting Diagnostic Tests for SARS-CoV-2

(2020) Nandini Sethuraman et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho

(2020) Andrew Bryan et al.   JOURNAL OF CLINICAL MICROBIOLOGY

The role of serology for COVID-19 control: Population, kinetics and test performance do matter

(2020) Marie Tré-Hardy et al.   JOURNAL OF INFECTION

Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19

(2020) Yafang Li et al.   JOURNAL OF MEDICAL VIROLOGY

Detection of antibodies against SARS-CoV-2 in patients with COVID-19

(2020) Zhe Du et al.   JOURNAL OF MEDICAL VIROLOGY

COVID‐19 patients' clinical characteristics, discharge rate, and fatality rate of meta‐analysis

(2020) Long‐quan Li et al.   JOURNAL OF MEDICAL VIROLOGY

A systematic review of asymptomatic infections with COVID-19

(2020) Zhiru Gao et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic

(2020) Wallace Brownlee et al.   NEUROLOGY

Multiple Sclerosis in the Campania Region (South Italy): Algorithm Validation and 2015–2017 Prevalence

(2020) Marcello Moccia et al.   International Journal of Environmental Research and Public Health

Evaluating the Risk of Macrovascular Events and Mortality Among People With Multiple Sclerosis in England

(2020) Raffaele Palladino et al.   JAMA Neurology

Antibody Tests in Detecting SARS-CoV-2 Infection: A Meta-Analysis

(2020) Panagiota I. Kontou et al.   Diagnostics

Perceived versus proven SARS-CoV-2-specific immune responses in health-care professionals

(2020) Georg M. N. Behrens et al.   INFECTION

SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients

(2020) Johannes Korth et al.   JOURNAL OF CLINICAL VIROLOGY

An Italian programme for COVID-19 infection in multiple sclerosis

(2020) Maria Pia Sormani   LANCET NEUROLOGY

COVID-19 in multiple sclerosis: The Dutch experience

(2020) Floor C Loonstra et al.   Multiple Sclerosis Journal

Multiple sclerosis management during the COVID-19 pandemic

(2020) Brandon P Moss et al.   Multiple Sclerosis Journal

Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis

(2020) Mayara Lisboa Bastos et al.   BMJ-British Medical Journal

Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis

(2020) Céline Louapre et al.   JAMA Neurology

Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study

(2020) Andrew Clark et al.   Lancet Global Health

Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain

(2020) Paloma Montero-Escribano et al.   Multiple Sclerosis and Related Disorders

Risk of COVID-19 infection in MS and neuromyelitis optica spectrum disorders

(2020) Moli Fan et al.   Neurology-Neuroimmunology & Neuroinflammation

Self-diagnosed COVID-19 in people with multiple sclerosis: a community-based cohort of the UK MS Register

(2020) Nikos Evangelou et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Response of the multiple sclerosis community to COVID-19

(2020) Olga Ciccarelli et al.   Multiple Sclerosis Journal

COVID-19 prevention and multiple sclerosis management: The SAFE pathway for the post-peak

(2020) Antonio Buonomo et al.   Multiple Sclerosis and Related Disorders

Mild or no COVID-19 symptoms in cladribine-treated multiple sclerosis: Two cases and implications for clinical practice

(2020) Marcello De Angelis et al.   Multiple Sclerosis and Related Disorders

Disease-modifying drugs for multiple sclerosis and infection risk: a cohort study

(2018) José Maria Andreas Wijnands et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

(2018) Alan J Thompson et al.   LANCET NEUROLOGY

Infectious Complications of Multiple Sclerosis Therapies: Implications for Screening, Prophylaxis, and Management

(2018) David J Epstein et al.   Open Forum Infectious Diseases

Mortality trends for multiple sclerosis patients in Sweden from 1968 to 2012

(2017) Sarah Burkill et al.   NEUROLOGY

Effect of comorbidity on mortality in multiple sclerosis

(2015) Ruth Ann Marrie et al.   NEUROLOGY